Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FDA
Recent news which mentions FDA
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
FDA Approves Insmed's Drug As First Treatment For Type Of Chronic Lung Disease
August 12, 2025
Tickers
INSM
NEWS
Tags
Top Stories
General
Movers
From
Benzinga
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
August 12, 2025
Tickers
AMPH
FMS
NEWS
VTRS
Tags
VTRS
why it's moving
Movers
From
Benzinga
FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
August 11, 2025
Tickers
MRNA
NEWS
NVAX
PFE
Tags
Government
Benzinga
NVAX
From
Benzinga
Vinay Prasad's Comeback To FDA Sparks Debate Over Regulatory Direction
August 11, 2025
Tickers
CABA
MRNA
NEWS
NGNE
Tags
Biotech
NVAX
FDA
From
Benzinga
Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue
August 08, 2025
Tickers
BSX
NEWS
Tags
Benzinga
Movers
why it's moving
From
Benzinga
RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies'
August 06, 2025
Tickers
MRNA
NVAX
PFE
Tags
Market News
MRNA
Health Care
From
Benzinga
Why Is Replimune Stock Trading Lower On Monday?
August 04, 2025
Tickers
BMY
NEWS
REPL
Tags
Biotech
Expert Ideas
FDA
From
Benzinga
Novo Nordisk's Alhemo Wins FDA Nod, Expanding Subcutaneous Option For Hemophilia Patients
August 01, 2025
Tickers
NEWS
NVO
SNY
Tags
Market News
News
Health Care
From
Benzinga
LENZ Therapeutics' Eye Drop Scores First FDA Approval For Age-Related Blurred Vision Condition Impacting 128 Million People
August 01, 2025
Tickers
LENZ
NEWS
Tags
Benzinga
LENZ
Market News
From
Benzinga
Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
August 01, 2025
Tickers
NEWS
NVO
REGN
SNY
Tags
Large Cap
Guidance
Benzinga
From
Benzinga
What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?
July 30, 2025
Tickers
CABA
CAPR
NEWS
NGNE
Tags
NGNE
CAPR
FDA
From
Benzinga
Sephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
July 29, 2025
Tickers
BMRN
NEWS
PTCT
Tags
Trading Ideas
BMRN
Benzinga
From
Benzinga
FDA Lifts Safety Hold On Sarepta's Muscular Dystrophy Gene Therapy—Wall Street Cheers
July 29, 2025
Tickers
NEWS
SRPT
Tags
General
Upgrades
Movers
From
Benzinga
FDA Approval For Empaveli Marks Key Milestone In Apellis' Rare Disease Portfolio
July 29, 2025
Tickers
APLS
NEWS
Tags
Expert Ideas
Biotech
FDA
From
Benzinga
Sarepta Therapeutics Stock Soars After FDA Removes Hold On Elevidys For Some Patients
July 28, 2025
Tickers
NEWS
SRPT
Tags
Biotech
FDA
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today